Controlled attenuation parameter for evaluating liver steatosis in type 2 diabetes patients

被引：0

作者：

Sporea, Ioan ^{[1
]}

Mare, Ruxandra ^{[1
]}

Lupusoru, Raluca ^{[1
]}

Silviu, Nistorescu ^{[1
]}

Popescu, Alina ^{[1
]}

Sirli, Roxana ^{[1
]}

Danila, Mirela ^{[1
]}

机构：

[1] Victor Babes Univ Med & Pharm, Gastroenterol & Hepatol, Timisoara, Romania

来源：

JOURNAL OF HEPATOLOGY | 2019年 / 70卷 / 01期

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

SAT-328

引用

页码：E784 / E784

页数：1

共 50 条

[41] Changes in liver steatosis evaluated by transient elastography with the controlled attenuation parameter in HIV-infected patients
Macias, J.
Real, L. M.
Rivero-Juarez, A.
Merchante, N.
Camacho, A.
Neukam, K.
Rivero, A.
Mancebo, M.
Pineda, J. A.
HIV MEDICINE, 2016, 17 (10) : 766 - 773
[42] Ultrasound and FibroScan® Controlled Attenuation Parameter in patients with MAFLD: head to head comparison in assessing liver steatosis
Andrea Salmi
Luigi di Filippo
Clarissa Ferrari
Stefano Frara
Andrea Giustina
Endocrine, 2022, 78 : 262 - 269
[43] Controlled attenuation parameter: A measure of hepatic steatosis in patients with cystic fibrosis
Bader, Razan M.
Jonas, Maureen M.
Mitchell, Paul D.
Wiggins, Shanna
Lee, Christine K.
JOURNAL OF CYSTIC FIBROSIS, 2019, 18 (02) : 280 - 285
[44] Effect of skin–capsular distance on controlled attenuation parameter for diagnosing liver steatosis in patients with nonalcoholic fatty liver disease
Syunichiro Kimura
Kenichi Tanaka
Satoshi Oeda
Kaori Inoue
Chika Inadomi
Yoshihito Kubotsu
Wataru Yoshioka
Michiaki Okada
Hiroshi Isoda
Takuya Kuwashiro
Takumi Akiyama
Aya Kurashige
Ayaka Oshima
Mayumi Oshima
Yasue Matsumoto
Atsushi Kawaguchi
Keizo Anzai
Eisaburo Sueoka
Shinichi Aishima
Hirokazu Takahashi
Scientific Reports, 11
[45] Vibration-Controlled Transient Elastography and Controlled Attenuation Parameter for the Diagnosis of Liver Steatosis and Fibrosis in Patients with Nonalcoholic Fatty Liver Disease
Zenovia, Sebastian
Stanciu, Carol
Sfarti, Catalin
Singeap, Ana-Maria
Cojocariu, Camelia
Girleanu, Irina
Dimache, Mihaela
Chiriac, Stefan
Muzica, Cristina Maria
Nastasa, Robert
Huiban, Laura
Cuciureanu, Tudor
Trifan, Anca
DIAGNOSTICS, 2021, 11 (05)
[46] Screening for nonalcoholic fatty liver disease and advanced liver fibrosis in patients with type 2 diabetes mellitus using controlled attenuation parameter and liver stiffness measurements
Lai, Lee Lee
Yusoff, Wan Nur Illyana Wan
Vethakkan, Shireene Ratna
Mustapha, Nik Raihan Nik
Chan, Wah Kheong
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2018, 33 : 424 - 424
[47] Transient Elastography with Controlled Attenuation Parameter (CAP) a tool for liver disease screening in type II diabetes mellitius patients
Sporea, Ioan
Lupusoru, Raluca
Mare, Ruxandra G.
Sirli, Roxana
Popescu, Alina
Nistorescu, Silviu
Timar, Romulus
HEPATOLOGY, 2017, 66 : 342A - 343A
[48] Accuracy of controlled attenuation parameter (CAP) measurement for the detection of steatosis in autoimmune liver diseases
Steinmann, Silja
Hartl, Johannes
Weidemann, Soeren Alexander
Katja, Fuessel
Kroll, Claudia
Lohse, Ansgar W.
Schramm, Christoph
JOURNAL OF HEPATOLOGY, 2023, 78 : S379 - S380
[49] Ultrasound-Guided Attenuation Parameter (UGAP) for the quantification of liver steatosis using the Controlled Attenuation Parameter (CAP) as the reference method
Bende, Felix
Sporea, Ioan
Sirli, Roxana
Baldea, Victor
Lazar, Alin
Lupusoru, Raluca
Fofiu, Renata
Popescu, Alina
MEDICAL ULTRASONOGRAPHY, 2021, 23 (01) : 7 - 14
[50] ULTRASOUND-GUIDED ATTENUATION PARAMETER (UGAP) FOR THE QUANTIFICATION OF LIVER STEATOSIS USING CONTROLLED ATTENUATION PARAMETER (CAP) AS THE REFERENCE METHOD
Bende, Felix
Sporea, Ioan
Baldea, Victor
Lazar, Alin
Lupusoru, Raluca
Fofiu, Renata
Popescu, Alina
Sirli, Roxana
GASTROENTEROLOGY, 2020, 158 (06) : S1411 - S1411

← 1 2 3 4 5 →